Concepedia

Author

Silvia Fenu

Fondazione IRCCS Istituto Neurologico Carlo BestaORCID

Also Known As

Daniela Calabrese, Fenu, Silvia, Fenu, silvia, S. Fenu, Silvia Esposito, Silvia Fenu

55

Publications

732

Citations

13

H-Index

18

Concepts

All Affiliations

Fondazione IRCCS Istituto Neurologico Carlo BestaIstituti di Ricovero e Cura a Carattere ScientificoUniversity of VeronaPoliclinico San Matteo FondazioneUniversity of Messina
SF

About

Silvia Fenu is an author at Fondazione IRCCS Istituto Neurologico Carlo Besta specializing in disease progression, medicine, and neurodegenerative diseases.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

104

2

Neurology

1

1

66

3

Pathology

1

1

66

4

Pharmacology

1

1

38

5

Clinical Microbiology

1

1

66

Silvia Fenu

×

11

Publications

527

Citations

11

H-Index

YearCitations

Spastic paraplegia due to SPAST mutations is modified by the underlying mutation and sex

Livia Parodi, Silvia Fenu, Mathieu Barbier,

Brain

2018

108

ATTRv amyloidosis Italian Registry: clinical and epidemiological data

Massimo Russo, Laura Obici, Ilaria Bartolomei,

Amyloid

2020

84

Normal and pathogenic variation of <i>RFC1</i> repeat expansions: implications for clinical diagnosis

Natalia Dominik, Stefania Magri, Riccardo Curró,

Brain

2023

66

Clinical and genetic keys to cerebellar ataxia due to FGF14 GAA expansions

Jean‐Loup Méreaux, Claire-Sophie Davoine, David Pellerin,

EBioMedicine

2023

52

Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus

Marina Grandis, Laura Obici, Marco Luigetti,

Orphanet Journal of Rare Diseases

2020

44

hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers

Marco Luigetti, Marina Romozzi, Giulia Bisogni,

Brain Sciences

2020

40

Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial

Wolfgang Köhler, Marc Engelen, Florian Eichler,

The Lancet Neurology

2023

38

Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients

Claudia Malacarne, M. Galbiati, Eleonora Giagnorio,

International Journal of Molecular Sciences

2021

32

Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis?

Ângela Romano, Guido Primiano, Giovanni Antonini,

European Journal of Neurology

2023

30

Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis

Alessandro Salvalaggio, Daniele Coraci, Laura Obici,

Journal of Neurology

2021

20

Page 1